[1]
|
Gajendran, M., Loganathan, P., Jimenez, G.,et al. (2019) A Comprehensive Review and Update on Ulcerative Colitis. Disease-a-Month, 65, Article ID: 100851. https://doi.org/10.1016/j.disamonth.2019.02.004
|
[2]
|
Ungaro, R., Mehandru, S., Allen, P.B., Peyrin-Biroulet, L. and Colombel, J.-F. (2017) Ulcerative Colitis. Lancet, 389, 1756-1770. https://doi.org/10.1016/S0140-6736(16)32126-2
|
[3]
|
Ko, C.W., Singh, S., Feuerstein, J.D., Falck-Ytter, C., et al. (2019) AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology, 156, 748-764.
https://doi.org/10.1053/j.gastro.2018.12.009
|
[4]
|
Kaenkumchorn, T. and Wahbeh, G. (2020) Ulcerative Colitis: Making the Diagnosis. Gastroenterology Clinics of North America, 49, 655-669. https://doi.org/10.1016/j.gtc.2020.07.001
|
[5]
|
Kobayashi, T., Siegmund, B., Le Berre, C., et al. (2020) Ulcerative Colitis. Nature Reviews Disease Primers, 6, Article No. 74. https://doi.org/10.1038/s41572-020-0205-x
|
[6]
|
Chutkan, R.K., Scherl, E. and Waye, J.D. (2002) Colonoscopy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America, 12, 463-483. https://doi.org/10.1016/S1052-5157(02)00007-7
|
[7]
|
Schuppan, D. (2000) Current Concepts of Celiac Disease Pathogenesis. Gastroenterology, 119, 234-242.
https://doi.org/10.1053/gast.2000.8521
|
[8]
|
Eisenstein, M. (2018) Ulcerative Colitis: Towards Remission. Nature, 563, S33.
https://doi.org/10.1038/d41586-018-07276-2
|
[9]
|
Andoh, A., Yoshida, T., Yagi, Y., et al. (2006) Increased Ag-gregation Response of Platelets in Patients with Inflammatory Bowel Disease. Journal of Gastroenterology, 41, 47-54. https://doi.org/10.1007/s00535-005-1721-x
|
[10]
|
Canero, A., Parmeggiani, D., Avenia, N., et al. (2012) Throm-boembolic Tendency (TE) in IBD (Inflammatory Bowel Disease) Patients. Annali Italiani di Chirurgia, 83, 313-317.
|
[11]
|
Danese, S., de la Motte, C. and Fiocchi, C. (2004) Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and therapeutic Implications. American Journal of Gastroenterology, 99, 938-945.
https://doi.org/10.1111/j.1572-0241.2004.04129.x
|
[12]
|
Schafer, A.I. (2001) Thrombocytosis and Thrombocythe-mia. Blood Reviews, 15, 159-166.
https://doi.org/10.1054/blre.2001.0162
|
[13]
|
Deutsch, V.R. and Tomer, A. (2013) Advances in Megakaryocytopoi-esis and Thrombopoiesis: From Bench to Bedside. British Journal of Haematology, 161, 778-793. https://doi.org/10.1111/bjh.12328
|
[14]
|
Koupenova, M., Kehrel, B.E., Corkrey, H.A. and Freedman, J.E. (2017) Thrombosis and Platelets: An Update. European Heart Journal, 38, 785-791. https://doi.org/10.1093/eurheartj/ehw550
|
[15]
|
Koupenova, M., Clancy, L., Corkrey, H.A. and Freedman, J.E. (2018) Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis. Circulation Research, 122, 337-351.
https://doi.org/10.1161/CIRCRESAHA.117.310795
|
[16]
|
Thomas, M.R. and Storey, R.F. (2015) The Role of Platelets in Inflammation. Thrombosis and Haemostasis, 114, 449-458.
https://doi.org/10.1160/TH14-12-1067
|
[17]
|
Tekelioglu, Y., Uzun, H. and Sisman, G. (2014) Activated Platelets in Patients Suffering from Inflammatory Bowel Disease. Bratislava Medical Journal, 115, 83-85. https://doi.org/10.4149/BLL_2014_018
|
[18]
|
Grewal, I.S. and Flavell, R.A. (1998) CD40 and CD154 in Cell-Mediated Immunity. Annual Review of Immunology, 16, 111-135. https://doi.org/10.1146/annurev.immunol.16.1.111
|
[19]
|
Danese, S., Katz, J.A., Saibeni, S., et al. (2003) Activated Platelets Are the Source of Elevated Levels of Soluble CD40 Ligand in the Circulation of Inflammatory Bowel Disease Patients. Gut, 52, 1435-1441.
https://doi.org/10.1136/gut.52.10.1435
|
[20]
|
Matsumoto, T. (2006) Platelets in Inflammatory Bowel Disease. Jour-nal of Gastroenterology, 41, 91-92.
https://doi.org/10.1007/s00535-006-1745-x
|
[21]
|
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D.C. and Sand-born, W.J. (2012) Ulcerative Colitis. Lancet, 380, 1606-1619. https://doi.org/10.1016/S0140-6736(12)60150-0
|
[22]
|
Bressler, B., Marshall, J.K., Bernstein, C.N., et al. (2015) Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus. Gastroenterology, 148, 1035-1058.
https://doi.org/10.1053/j.gastro.2015.03.001
|
[23]
|
常明霞. α-干扰素联合羟基脲治疗原发性血小板增多症的效果[J]. 临床医学, 2022, 42(2): 113-114.
|
[24]
|
Cortelazzo, S., Finazzi, G., Ruggeri, M., et al. (1995) Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis. The New England Journal of Medicine, 332, 1132-1136.
https://doi.org/10.1056/NEJM199504273321704
|
[25]
|
Weyrich, A.S. and Zimmerman, G.A. (2004) Platelets: Sig-naling Cells in the Immune Continuum. Trends in Immunology, 25, 489-495. https://doi.org/10.1016/j.it.2004.07.003
|